Affinage

AP4M1

AP-4 complex subunit mu-1 · UniProt O00189

Length
453 aa
Mass
50.0 kDa
Annotated
2026-04-28
23 papers in source corpus 5 papers cited in narrative 5 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

AP4M1 encodes the mu subunit of adaptor protein complex-4 (AP-4), a heterotetrameric coat complex that mediates intracellular membrane trafficking, particularly of glutamate receptors in neurons (PMID:9013859, PMID:19559397). Loss-of-function mutations in AP4M1 cause aberrant localization of the GluRδ2 glutamate receptor and abnormal dendritic spine morphology in human brain tissue, establishing its essential role in neuronal receptor sorting (PMID:19559397). AP4M1 is required for normal AP-4 complex activity, and AAV-mediated gene replacement rescues loss-of-function phenotypes in both patient-derived fibroblasts and Ap4m1-knockout mice, confirming AP4M1 deficiency as the direct cause of AP-4 deficiency syndrome (spastic paraplegia 50) (PMID:33553621, PMID:36951961).

Mechanistic history

Synthesis pass · year-by-year structured walk · 5 steps
  1. 1997 Low

    Identification of AP4M1 as a novel mu-adaptin homolog predicted it to function as the medium subunit of a previously unrecognized adaptor protein coat complex involved in vesicular trafficking.

    Evidence cDNA cloning and primary structure analysis with tissue distribution profiling

    PMID:9013859

    Open questions at the time
    • No functional assay performed; role inferred solely from sequence homology
    • Whether AP4M1 assembles into a functional adaptor complex was not demonstrated
    • Cargo specificity unknown
  2. 2009 Medium

    Demonstrating that homozygous AP4M1 loss-of-function mutation causes mislocalization of GluRδ2 and aberrant dendritic spines established AP4M1 as essential for neuronal glutamate receptor trafficking and linked it to a Mendelian neurological disorder.

    Evidence Immunohistochemistry and histology on postmortem brain tissue from patients with homozygous splice-site mutation in AP4M1

    PMID:19559397

    Open questions at the time
    • Single study based on postmortem tissue; no in vitro reconstitution of AP4M1-dependent trafficking
    • Whether GluRδ2 is a direct AP-4 cargo or mislocalized secondarily was not resolved
    • Mechanism by which AP4M1 recognizes cargo sorting signals was not defined
  3. 2014 Low

    Observation that AP4M1 redistributes from dendrites to axons during ischemic stress suggested its trafficking role is dynamically regulated in neurons, though functional consequences remained uncharacterized.

    Evidence Immunofluorescent co-labeling with MAP2 and Tau-1, RT-PCR and western blotting in primary hippocampal neurons subjected to oxygen-glucose deprivation

    PMID:24486887

    Open questions at the time
    • No functional consequence of redistribution was established
    • Mechanism driving AP4M1 redistribution under ischemia is unknown
    • Not independently confirmed in additional models
  4. 2020 Medium

    Confirming that a patient-derived AP4M1 loss-of-function variant abolishes AP-4 complex function in fibroblasts established AP4M1 as indispensable for AP-4 assembly or activity.

    Evidence Functional studies in patient-derived fibroblasts carrying AP4M1 c.59-1G>C variant

    PMID:33553621

    Open questions at the time
    • Single lab with single method; biochemical basis of complex disruption not detailed
    • Whether AP-4 complex fails to assemble or assembles but is non-functional was not distinguished
  5. 2023 High

    AAV-mediated AP4M1 gene replacement rescued defects in patient fibroblasts and Ap4m1-KO mice in a dose- and age-dependent manner, proving that AP4M1 loss is both necessary and sufficient to explain AP-4 deficiency phenotypes.

    Evidence AAV2/AP4M1 transduction of patient fibroblasts (in vitro) and intrathecal AAV9/AP4M1 injection in Ap4m1-KO mice (in vivo) with dose-response, plus toxicology in WT mice, rats, and non-human primates

    PMID:36951961

    Open questions at the time
    • Precise molecular cargoes sorted by reconstituted AP-4 were not identified beyond GluRδ2
    • Long-term durability of gene therapy rescue in neurons not established
    • Structural basis for AP4M1 cargo recognition signal binding remains undefined

Open questions

Synthesis pass · forward-looking unresolved questions
  • The direct cargo recognition mechanism of AP4M1 within the AP-4 complex — including sorting signal specificity, structural basis of substrate binding, and the full spectrum of AP-4-dependent cargoes — remains uncharacterized.
  • No structural model of AP4M1-cargo interaction exists
  • Full repertoire of AP-4 cargoes beyond GluRδ2 is undefined
  • Regulation of AP4M1/AP-4 by phosphorylation or other post-translational modifications is unexplored

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 3
Localization
GO:0031410 cytoplasmic vesicle 2 GO:0005829 cytosol 1
Pathway
R-HSA-5653656 Vesicle-mediated transport 3 R-HSA-112316 Neuronal System 2
Partners
Complex memberships
AP-4

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2009 AP4M1, encoding the mu subunit of adaptor protein complex-4 (AP-4), is involved in intracellular trafficking of glutamate receptors; loss-of-function mutation in AP4M1 leads to aberrant GluRdelta2 glutamate receptor localization and abnormal dendritic spine morphology in postmortem brain tissue. Immunohistochemistry and histology on postmortem brain tissue from patients with homozygous splice-site mutation in AP4M1 American journal of human genetics Medium 19559397
1997 AP4M1 (mu-ARP2) is a mu-adaptin-related protein with sequence homology to the medium chains of clathrin coat adaptor complexes, suggesting a role as a subunit of a novel type of clathrin- or non-clathrin-associated protein coat involved in cellular membrane traffic. cDNA cloning, primary structure analysis, and tissue distribution profiling FEBS letters Low 9013859
2014 AP4M1 protein is localized to dendrites in normal hippocampal neurons but redistributes to axons following oxygen-glucose deprivation, and its expression is downregulated at both mRNA and protein levels after ischemic injury. Immunofluorescent co-labeling with MAP2 and Tau-1, real-time PCR and western blotting in primary cultured hippocampal neurons subjected to OGD Neuroscience letters Low 24486887
2023 AAV9/AP4M1 gene therapy rescues the loss-of-function phenotype in AP4M1-deficient patient fibroblasts in vitro and in Ap4m1-KO mice in vivo, confirming that AP4M1 is necessary for normal neuronal function and that its restoration is sufficient for phenotypic rescue. Transduction of patient-derived fibroblasts with AAV2/AP4M1 (in vitro rescue), intrathecal injection of AAV9/AP4M1 in Ap4m1-KO mice with dose- and age-dependent efficacy assessment (in vivo), toxicology studies in WT mice, rats, and non-human primates The Journal of clinical investigation High 36951961
2020 Functional studies in patient-derived fibroblasts with a loss-of-function AP4M1 variant confirmed loss of adaptor protein complex 4 function, establishing AP4M1 as essential for AP-4 complex activity. Functional studies in patient-derived fibroblasts carrying AP4M1 variant (c.59-1G>C) Neurology. Genetics Medium 33553621

Source papers

Stage 0 corpus · 23 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1989 The regulated production of mu m and mu s mRNA is dependent on the relative efficiencies of mu s poly(A) site usage and the c mu 4-to-M1 splice. Molecular and cellular biology 157 2565533
2009 Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. American journal of human genetics 140 19559397
2014 Autosomal recessive spastic tetraplegia caused by AP4M1 and AP4B1 gene mutation: expansion of the facial and neuroimaging features. American journal of medical genetics. Part A 57 24700674
2002 Electronic structure description of the mu(4)-sulfide bridged tetranuclear Cu(Z) center in N(2)O reductase. Journal of the American Chemical Society 56 11817937
2002 Spectroscopic and electronic structure studies of the mu(4)-sulfide bridged tetranuclear Cu(Z) cluster in N(2)O reductase: molecular insight into the catalytic mechanism. Journal of the American Chemical Society 53 12197752
2023 Intrathecal AAV9/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies. The Journal of clinical investigation 36 36951961
2014 A novel AP4M1 mutation in autosomal recessive cerebral palsy syndrome and clinical expansion of AP-4 deficiency. BMC medical genetics 27 25496299
1997 Identification of two new mu-adaptin-related proteins, mu-ARP1 and mu-ARP2. FEBS letters 22 9013859
1964 CALCIUM ION REQUIREMENT FOR PROLIFERATION OF BACTERIOPHAGE PHI MU-4. Journal of bacteriology 22 14203343
1964 Isolation and preliminary characterization of bacteriophage phi-mu-4. Journal of bacteriology 20 5874550
1997 Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q. Journal of immunology (Baltimore, Md. : 1950) 15 9317134
2017 Severe congenital microcephaly with AP4M1 mutation, a case report. BMC medical genetics 10 28464862
2020 Blended Phenotype of Silver-Russell Syndrome and SPG50 Caused by Maternal Isodisomy of Chromosome 7. Neurology. Genetics 9 33553621
2014 AP4M1 is abnormally expressed in oxygen-glucose deprived hippocampal neurons. Neuroscience letters 5 24486887
2023 Identification of novel homozygous variants in FOXE3 and AP4M1 underlying congenital syndromic anophthalmia and microphthalmia. The journal of gene medicine 4 37758467
2021 Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4M1-associated hereditary spastic paraplegia (SPG50). Stem cell research 4 34087981
2012 catena-Poly[[[bis-[μ-3-(4-carb-oxy-phen-oxy)propionato]-κO,O:O;κO:O,O-bis-[aqua-(N,N-dimethyl-formamide-κO)cadmium]]-μ-4,4'-bipyridine-κN:N'] dinitrate]. Acta crystallographica. Section E, Structure reports online 1 22346877
1995 A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands. International immunology 1 7734425
2026 A Novel AP4M1 Variant in an Iranian Child with Spastic Paraplegia 50: A Case Report and Molecular Docking Approach. Iranian journal of medical sciences 0 41625348
2013 The double-stranded ladder-like structure of poly[[bis(μ2-acetato-κ(2)O:O')bis(acetato-κO)bis(μ-4,4'-bipyridine-κ(2)N:N')dicopper(II)] 4-nitrophenol disolvate tetrahydrate]. Acta crystallographica. Section C, Crystal structure communications 0 24096493
2012 Decacarbon-yl[μ(4)-(ethane-1,2-diyl-dinitrilo)-tetra-kis-(methane-thiol-ato)]bis(triphenyl-phosphane)tetra-iron(2 Fe-Fe). Acta crystallographica. Section E, Structure reports online 0 22346806
2012 μ-4,4'-Bipyridine-κ2N:N'-bis[tetraaqua(4,4'-bipyridine-κN)dimanganese(II)] bis(4-aminobenzoate) bis(perchlorate)-4,4'-bipyridine-water (1/2/4): a supramolecular system constructed by π-π and hydrogen-bond interactions. Acta crystallographica. Section C, Crystal structure communications 0 22935493
2010 Poly[[tetraaquadi-μ(4)-glutarato-μ(2)-terephthalato-dineodymium(III)] heptadecahydrate]. Acta crystallographica. Section C, Crystal structure communications 0 21123880